行情

VNRX

VNRX

VOLITIONRX
AMEX

实时行情|Nasdaq Last Sale

4.740
-0.050
-1.04%
休市 16:00 01/17 EST
开盘
4.820
昨收
4.790
最高
4.850
最低
4.690
成交量
3.99万
成交额
--
52周最高
6.84
52周最低
2.110
市值
1.95亿
市盈率(TTM)
-10.5521
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

VNRX 新闻

  • 英国央行行长称:全球经济正陷入“流动性陷阱”
  • 新浪美股.3小时前
  • 弹劾案审讯开始在即 民主党人、特朗普律师提交主张
  • 新浪财经.3小时前
  • 利比亚输油管线和谈前被关闭 或加剧石油供应中断
  • 新浪财经.4小时前
  • 使用同一"排名最低"供应商 波音777X重现MAX安全问题
  • 新浪美股.4小时前

更多

所属板块

医疗设备、用品及经销
+0.07%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

VNRX 简况

VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.
展开

Webull提供VolitionRX Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。